Would you like to see Taiwan’s Leading Cell Therapy Processing Plants in Action?
You can witness Taiwan’s leading Cell Therapy Processing Plants in Action this April! We are pleased to inform you that Medigen Vaccine Biologics. Co (MVC) & UnicoCell Biomed have confirmed to give 20 participants a tour of their cell therapy processing plants on the 7 April 2020, Taipei.
About MVC’s Cell Therapy Processing Plant
Name: Site Tour to Newly Built and Largest Cell Processing Center in Taiwan
Address: No. 68號, Shengyi 3rd Road, Zhubei City, Hsinchu County, Taiwan 30261
Description: Medigen Vaccine Biologics Corporation specializing in cell culture vaccine production and aseptic preparation operations, in addition to having obtained PIC/S GMP vaccine factory verification, are optimistic about the technological relevance and market prospects of the cell therapy production supply chain, is building the highest level and largest Cell Processing Centre (CPC) in Taiwan and plan to provide capacity development and assistance to CDMO in contract development and manufacturing.
About UnicoCell Biomed’s Cell Therapy Processing Plant
Name: Site Tour to Newly Built Cell Processing Centre by UnicoCell Biomed CO. LTD
Address: 1494 台北市內湖區民權東路六段13之19號6樓 (6F., No. 13-19, Sec. 6, Minquan E. Rd., Neihu Dist., Taipei City 114, Taiwan)
Description: UnicoCell BioMed is a biotech company in Taiwan and focus on stem cell drug development and cell therapy technology development. Our main capabilities include professional cell therapy R & D experience and cell mass manufacturing process technology. We have two cell processing centers, including GTP laboratory and PIC/S GMP cell factory. The main products and services are as follows:
- “ELIXCYTE®”, The new stem cell drug, is an allogeneic adipose stem cell product for treating knee osteoarthritis and chronic kidney disease. It is currently in the phase I/II clinical trials (US-FDA, TFDA IND
- “UnicoVial®” –Old school, new design/patented cyrotube & Drug container, is an ideal biopreservation container system for cell therapy product, providing for closure integrity, sample stability and ready access to clinical use.
- “Perfectin® ” –Industrial production of Adipose stem cell derived factors and exosomes for cosmetic & medicinal use.
- Licensed autologous cell therapy services.
- The safety test, MOAs & potency assay services of cell products.